Crossref
CAR-T Cell-Based Immunotherapy
INFM-OAR (INFN Catania) · 15.08.2023
DOI: 10.15161/oar.it/77176 ↗Kurz gefasst
Fachartikel in der Zeitschrift INFM-OAR (INFN Catania), erschienen am 15.08.2023. Verfasst von Cailynn.
Abstract (Originalsprache)
Over the past decade, great progress has been made in the field of immunotherapy, especially in the field of T cell therapy. Chimeric antigen receptor (CAR)-engineered T cell therapy is the most promising approach, which has shown remarkable ability in the elimination of a variety of tumors.
Schlagwörter
CAR T-cell therapychimeric antigen receptorT cell engineeringcancer immunotherapytumor eradication
Zitieren
APA
Cailynn (2023). CAR-T Cell-Based Immunotherapy. INFM-OAR (INFN Catania). https://doi.org/10.15161/oar.it/77176
Vancouver
Cailynn. CAR-T Cell-Based Immunotherapy. INFM-OAR (INFN Catania). 2023. doi:10.15161/oar.it/77176
BibTeX
@article{Cailynn2023,
author = {Cailynn},
title = {CAR-T Cell-Based Immunotherapy},
journal = {INFM-OAR (INFN Catania)},
year = {2023},
doi = {10.15161/oar.it/77176}
}
EUVIMED